Molecules in medicine mini review: The αβ T cell receptor

Journal of Molecular Medicine

Volumn 92, Issue 7, 2014, Pages 735-741

  Clambey, Eric T ^a,b   Davenport, Bennett ^a,b   Kappler, John W ^b,c   Marrack, Philippa ^b,c   Homann, Dirk ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Major histocompatibility complex; T cell receptor; T cell repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; CELL FATE; CELL FUNCTION; CELL MATURATION; CELL SPECIFICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS; GENETICS; HUMAN; IMMUNOLOGY; VDJ RECOMBINATION;

HUMANS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; THYMUS GLAND; V(D)J RECOMBINATION;

EID: 84903306474     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1145-2     Document Type: Review

References (53)

1. Allison JP, McIntyre BW, Bloch D (1982) Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. J Immunol 129:2293-2300 (Pubitemid 12004412)
2. Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Schlossman SF, Reinherz EL (1983) Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med 157:705-719 (Pubitemid 13145070)
3. Haskins K, Kubo R, White J, Pigeon M, Kappler J, Marrack P (1983) The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med 157:1149-1169 (Pubitemid 13083697)
4. Kappler J, Kubo R, Haskins K, Hannum C, Marrack P, Pigeon M, McIntyre B, Allison J, Trowbridge I (1983) The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell 35:295-302 (Pubitemid 14240240)
5. Hedrick SM, Cohen DI, Nielsen EA, Davis MM (1984) Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308:149-153 (Pubitemid 14129555)
6. Hedrick SM, Nielsen EA, Kavaler J, Cohen DI, Davis MM (1984) Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature 308:153-158 (Pubitemid 14129556)
7. Chien YH, Gascoigne NR, Kavaler J, Lee NE, Davis MM (1984) Somatic recombination in a murine T-cell receptor gene. Nature 309:322-326 (Pubitemid 14145832)
8. Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW (1984) A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature 308:145-149 (Pubitemid 14129554)
9. Weiss A (2005) Discovering the TCR beta-chain by subtraction. J Immunol 175:2769-2770
10. Nikolich-Zugich J, Slifka MK, Messaoudi I (2004) The many important facets of T-cell repertoire diversity. Nat Rev Immunol 4:123-132 (Pubitemid 38209206)
11. Hale JS, Fink PJ (2010) T-cell receptor revision: friend or foe? Immunology 129:467-473
12. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA (2008) Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 205:711-723 (Pubitemid 351439315)
13. Cheng MH, Anderson MS (2012) Monogenic autoimmunity. Annu Rev Immunol 30:393-427
14. Marrack P, Kappler JW (2012) Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harbor perspectives in medicine 2:a007765
15. Sullivan BA, Kronenberg M (2007) TCR-mediated recognition of glycolipid CD1 complexes. Curr Top Microbiol Immunol 314:165-193
16. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O (2011) Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32:212-218
17. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CS (2012) A broad range of self-reactivity drives thymic regulatory Tcell selection to limit responses to self. Immunity 37:475-486
18. Herzog J, Maekawa Y, Cirrito TP, Illian BS, Unanue ER (2005) Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc Natl Acad Sci U S A 102:7928-7933 (Pubitemid 40781040)
19. Delong T, Baker RL, He J, Barbour G, Bradley B, Haskins K (2012) Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes 61:3239-3246
20. + T cells in chronic beryllium disease. J Exp Med 210:1403-1418
21. Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, Wijeyewickrema LC, Eckle SB, van Heemst J, Pike RN et al (2013) A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med 210:2569-2582
22. Dai S, Falta MT, Bowerman NA, McKee AS, Fontenot AP (2013) T cell recognition of beryllium. Curr Opin Immunol.
23. Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, Pellicci DG, Patel O, Vivian JP, Matsuda JL, McCluskey J et al (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315-326
24. Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, Sullivan LC, Keshipeddy S, Young MH, Uldrich AP, Thakur MS et al (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34:327-339
25. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R et al (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491:717-723
26. Young MH, U'Ren L, Huang S, Mallevaey T, Scott-Browne J, Crawford F, Lantz O, Hansen TH, Kappler J, Marrack P et al (2013) MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One 8:e53789
27. Coppieters KT, von Herrath MG, Homann D (2013) Autoimmunity and autoimmune diseases. In: Paul W (ed) Fundamental IMMUNOLOGY Lippincott Williams & Wilkins, Philadelphia.
28. Surh CD, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity 29:848-862
29. Yin L, Dai S, Clayton G, Gao W, Wang Y, Kappler J, Marrack P (2013) Recognition of self and altered self by T cells in autoimmunity and allergy. Protein cell 4:8-16
30. Evavold BD, Allen PM (1991) Separation of IL-4 production from Th cell proliferation by an altered Tcell receptor ligand. Science 252:1308-1310 (Pubitemid 21917045)
31. Morris GP, Allen PM (2012) How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol 13:121-128
32. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas De St Groth B, Davis MM (1991) Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788-1791 (Pubitemid 21917527)
33. Stone JD, Chervin AS, Kranz DM (2009) T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 126:165-176
34. van der Merwe PA, Dushek O (2011) Mechanisms for T cell receptor triggering. Nat Rev Immunol 11:47-55
35. Blanco R, Alarcon B (2012) TCR nanoclusters as the framework for transmission of conformational changes and cooperativity. Front Immunol 3:115
36. Kuhns MS, Davis MM (2012) TCR Signaling Emerges from the Sum of Many Parts. Front Immunol 3:159
37. Salomon B, Bluestone JA (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225-252 (Pubitemid 32368035)
38. Curtsinger JM, Mescher MF (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22:333-340
39. Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704 (Pubitemid 351600389)
40. Schietinger A, Greenberg PD (2013) Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol.
41. Zhu Y, Yao S, Chen L (2011) Cell surface signaling molecules in the control of immune responses: a tide model. Immunity 34:466-478
42. + T-cell cross-reactivity and heterologous immunity. Immunol Rev 211:164-181
43. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P (1993) Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 9:101-128
44. Li H, Llera A, Malchiodi EL, Mariuzza RA (1999) The structural basis of T cell activation by superantigens. Annu Rev Immunol 17:435-466 (Pubitemid 29241131)
45. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J (2011) The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Immunol Cell Biol 89:388-395
46. Felix NJ, Allen PM (2007) Specificity of T-cell alloreactivity. Nat Rev Immunol 7:942-953 (Pubitemid 350166059)
47. Altman JD, Davis MM (2003) MHC-peptide tetramers to visualize antigen-specific Tcells. Curr Protoc Immunol Chapter 17: Unit 17 13.
48. Nepom GT (2012) MHC class II tetramers. J Immunol 188:2477-2482
49. + T cell phenotypes. Immunity 36:142-152
50. + T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722
51. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A et al (2013) Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359-1365
52. Kalos M, June CH (2013) Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 39:49-60
53. Rosenberg SA (2012) Raising the bar: the curative potential of human cancer immunotherapy. Sci Transl Med 4:127ps128.